When should palliative care be introduced for people with progressive fibrotic interstitial lung disease? A meta-ethnography of the experiences of people with end-stage interstitial lung disease and their family carers.
Interstitial lung disease
meta-ethnography
palliative care
qualitative research
Journal
Palliative medicine
ISSN: 1477-030X
Titre abrégé: Palliat Med
Pays: England
ID NLM: 8704926
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
pubmed:
14
6
2022
medline:
9
9
2022
entrez:
13
6
2022
Statut:
ppublish
Résumé
Little is currently known about the perspectives of people with interstitial lung disease and their carers in relation to the timing of palliative care conversations. To establish patients' and carers' views on palliative care in interstitial lung disease and identify an optimum time to introduce the concept of palliative care. Meta-ethnography of qualitative evidence. The review protocol was prospectively registered with PROSPERO (CRD42021243179). Five electronic healthcare databases were searched (Medline, Embase, CINAHL, Scopus and Web of Science) from 1st January 1996 to 31st March 2022. Studies were included that used qualitative methodology and included patients' or carers' perspectives on living with end-stage disease or palliative care. Quality was assessed using the Critical Appraisal Skills Programme checklist. About 1779 articles were identified by initial searches. Twelve met the inclusion criteria, providing evidence from 266 individuals across five countries. Three stages were identified in the illness journey of a person with interstitial lung disease: (1) Information seeking, (2) Grief and adjustment, (3) Fear of the future. Palliative care involvement was believed to be most appropriate in the latter two stages and should be prompted by changes in patients' health such as respiratory infections, onset of new symptoms, hospital admission, decline in physical function and initiation of oxygen. Patients and carers prefer referral to palliative care services to be prompted by changes in health status. Future research should focus on supporting timely recognition of changes in patients' health status and how to respond in a community setting.
Sections du résumé
BACKGROUND
Little is currently known about the perspectives of people with interstitial lung disease and their carers in relation to the timing of palliative care conversations.
AIM
To establish patients' and carers' views on palliative care in interstitial lung disease and identify an optimum time to introduce the concept of palliative care.
DESIGN
Meta-ethnography of qualitative evidence. The review protocol was prospectively registered with PROSPERO (CRD42021243179).
DATA SOURCES
Five electronic healthcare databases were searched (Medline, Embase, CINAHL, Scopus and Web of Science) from 1st January 1996 to 31st March 2022. Studies were included that used qualitative methodology and included patients' or carers' perspectives on living with end-stage disease or palliative care. Quality was assessed using the Critical Appraisal Skills Programme checklist.
RESULTS
About 1779 articles were identified by initial searches. Twelve met the inclusion criteria, providing evidence from 266 individuals across five countries. Three stages were identified in the illness journey of a person with interstitial lung disease: (1) Information seeking, (2) Grief and adjustment, (3) Fear of the future. Palliative care involvement was believed to be most appropriate in the latter two stages and should be prompted by changes in patients' health such as respiratory infections, onset of new symptoms, hospital admission, decline in physical function and initiation of oxygen.
CONCLUSIONS
Patients and carers prefer referral to palliative care services to be prompted by changes in health status. Future research should focus on supporting timely recognition of changes in patients' health status and how to respond in a community setting.
Identifiants
pubmed: 35694777
doi: 10.1177/02692163221101753
pmc: PMC9446428
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1171-1185Références
Health Soc Work. 2009 Feb;34(1):41-51
pubmed: 19281101
J Health Serv Res Policy. 2002 Oct;7(4):209-15
pubmed: 12425780
Thorax. 2016 Jun;71(6):510-6
pubmed: 26865603
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Soc Sci Med. 2014 Nov;120:190-8
pubmed: 25259657
COPD. 2018 Dec;15(6):600-611
pubmed: 30714417
Circ Heart Fail. 2020 Sep;13(9):e006881
pubmed: 32900233
Respir Res. 2019 May 24;20(1):103
pubmed: 31126287
Lung. 2012 Apr;190(2):215-20
pubmed: 22218887
J Pain Symptom Manage. 2018 Feb;55(2):420-426
pubmed: 29101086
Psychophysiology. 2012 Jun;49(6):829-32
pubmed: 22416851
Heart Lung. 2017 Jan - Feb;46(1):24-29
pubmed: 27871724
Respir Med. 2019 Jan;146:129-136
pubmed: 30665511
BMC Pulm Med. 2011 Feb 11;11:9
pubmed: 21314932
Palliat Med. 2013 Oct;27(9):869-76
pubmed: 23885010
Chest. 2015 Feb;147(2):423-429
pubmed: 25187973
Disabil Rehabil. 2012;34(16):1367-75
pubmed: 22256892
Ann Am Thorac Soc. 2016 Jul;13(7):1026-33
pubmed: 27064659
J Gen Intern Med. 2002 Oct;17(10):749-55
pubmed: 12390550
Syst Rev. 2016 May 04;5:74
pubmed: 27145932
BMC Pulm Med. 2018 May 22;18(1):78
pubmed: 29788938
Am J Hosp Palliat Care. 2022 Jun;39(6):641-651
pubmed: 34433294
Health Technol Assess. 2011 Dec;15(43):1-164
pubmed: 22176717
ERJ Open Res. 2019 Jun 04;5(2):
pubmed: 31192248
BMC Med Res Methodol. 2019 Jan 31;19(1):25
pubmed: 30709371
Qual Health Res. 2006 Jan;16(1):162-8
pubmed: 16317183
Respir Res. 2019 Nov 12;20(1):253
pubmed: 31718645
BMC Med Res Methodol. 2008 Apr 16;8:21
pubmed: 18416812
BMC Pulm Med. 2015 Dec 04;15:155
pubmed: 26637194
J Gen Intern Med. 2000 Mar;15(3):195-200
pubmed: 10718901
Am J Hosp Palliat Care. 2021 Feb;38(2):154-160
pubmed: 32648528
J Am Med Dir Assoc. 2014 Jul;15(7):477-489
pubmed: 24598477
J Adv Nurs. 2015 May;71(5):1055-65
pubmed: 25533573
Res Synth Methods. 2021 Jan;12(1):55-61
pubmed: 32336025
BMC Health Serv Res. 2021 Jan 8;21(1):50
pubmed: 33419430
BMJ Open Respir Res. 2020 Mar;7(1):
pubmed: 32169831
Palliat Med. 2014 Sep;28(8):1000-25
pubmed: 24651708
Palliat Support Care. 2014 Dec;12(6):465-72
pubmed: 23916195
Sociol Health Illn. 1983 Jul;5(2):168-95
pubmed: 10261981
Am J Hosp Palliat Care. 2021 Feb;38(2):104-113
pubmed: 32431183
Chron Respir Dis. 2015 May;12(2):93-101
pubmed: 25687210
J Health Serv Res Policy. 2007 Jan;12(1):42-7
pubmed: 17244397
BMJ Open Respir Res. 2014 Jan 03;1(1):e000007
pubmed: 25478168
BMJ Support Palliat Care. 2021 Apr 8;:
pubmed: 33832967
Chron Respir Dis. 2011;8(4):225-31
pubmed: 21856780
Am J Respir Crit Care Med. 2011 Oct 1;184(7):842-7
pubmed: 21719755
ERJ Open Res. 2017 Apr 27;3(2):
pubmed: 28462236
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Respirology. 2019 Mar;24(3):270-277
pubmed: 30282111
Sci Rep. 2021 Apr 28;11(1):9184
pubmed: 33911185
Eur Respir J. 2016 May;47(5):1472-80
pubmed: 26846831
Palliat Med. 2021 Feb;35(2):261-279
pubmed: 33339475
Thorax. 2021 Mar;76(3):248-255
pubmed: 33298580
BMC Public Health. 2019 Apr 23;19(1):422
pubmed: 31014309
BMJ Open Qual. 2018 Jan 30;7(1):e000207
pubmed: 29464212
BMJ Support Palliat Care. 2013 Mar;3(1):84-90
pubmed: 24644332
J Neurol Sci. 1998 Oct;160 Suppl 1:S114-21
pubmed: 9851660
Palliat Med. 2018 Oct;32(9):1455-1464
pubmed: 30056786
ERJ Open Res. 2018 May 18;4(2):
pubmed: 29796390
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48
pubmed: 24032382
Thorax. 2018 Mar;73(3):222-230
pubmed: 29109233
Can J Respir Ther. 2019 Sep 16;55:73-80
pubmed: 31595226
Chron Respir Dis. 2014 Nov;11(4):209-28
pubmed: 25252693